Detalles de la búsqueda
1.
Derivation and validation of actionable quality indicators targeting reductions in complications for injury admissions.
Eur J Trauma Emerg Surg
; 48(2): 1351-1361, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961073
2.
Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation.
Cancer Res
; 71(16): 5535-45, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21705440
3.
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097.
Mol Oncol
; 5(3): 292-301, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21315665
4.
Preclinical in vivo evaluation of efficacy, pharmacokinetics, and pharmacodynamics of a novel MEK1/2 kinase inhibitor RO5068760 in multiple tumor models.
Mol Cancer Ther
; 9(1): 134-44, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20053779
Resultados
1 -
4
de 4
1
Próxima >
>>